Bioanalytical Systems (NASDAQ:BASI) Earning Somewhat Positive Press Coverage, Analysis Finds

Headlines about Bioanalytical Systems (NASDAQ:BASI) have trended somewhat positive this week, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Bioanalytical Systems earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.3130751516791 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of Bioanalytical Systems (NASDAQ BASI) remained flat at $$2.81 during mid-day trading on Monday. 123,716 shares of the company traded hands, compared to its average volume of 160,506. Bioanalytical Systems has a 12 month low of $0.65 and a 12 month high of $2.95. The company has a quick ratio of 0.51, a current ratio of 0.64 and a debt-to-equity ratio of 0.60.

TRADEMARK VIOLATION NOTICE: “Bioanalytical Systems (NASDAQ:BASI) Earning Somewhat Positive Press Coverage, Analysis Finds” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/11/bioanalytical-systems-basi-receiving-somewhat-positive-media-coverage-analysis-shows.html.

About Bioanalytical Systems

Bioanalytical systems, Inc is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies.

Insider Buying and Selling by Quarter for Bioanalytical Systems (NASDAQ:BASI)

Receive News & Ratings for Bioanalytical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply